leadf
logo-loader
LSE:SCLP FRA:SCP

Scancell Holdings PLC

Receive alerts
Market:
LSE
Market Cap:
£102.91 m
Price
14.25 GBX
Change
0.00%
52 weeks high
20.71
52 weeks low
4.16

In brief

Scancell's primary focus is to develop innovative immunotherapies for cancer that stimulate the body’s own immune system. A key challenge in the fight against cancer is that many tumours successfully evade the body’s own natural defences. Scancell’s mission is to overcome this by developing products that stimulate the immune system to treat or prevent cancer.

Snapshot

  • Developing innovative cancer immunotherapies
  • Four lead products in development
  • Working on a coronavirus vaccine